BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16296788)

  • 1. Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
    Alberti I; Grenier A; Kraus H; Carrara DN
    Expert Opin Drug Deliv; 2005 Sep; 2(5):935-50. PubMed ID: 16296788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Maturitas; 2012 Sep; 73(1):74-80. PubMed ID: 22325243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal testosterone gel (Cellegy).
    McGriff-Lee NJ
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1629-32. PubMed ID: 12476964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin.
    Nicoli S; Penna E; Padula C; Colombo P; Santi P
    Int J Pharm; 2006 Nov; 325(1-2):2-7. PubMed ID: 16860952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of testosterone.
    Hadgraft J; Lane ME
    Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery systems.
    Merkle HP
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):135-53. PubMed ID: 2657273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
    So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
    Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
    Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
    Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chirality and its implications in transdermal drug development.
    Reddy IK; Kommuru TR; Zaghloul AA; Khan MA
    Crit Rev Ther Drug Carrier Syst; 2000; 17(4):285-325. PubMed ID: 10958245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent chemical enhancer formulations for transdermal drug delivery: more is not always better.
    Arora A; Kisak E; Karande P; Newsam J; Mitragotri S
    J Control Release; 2010 Jun; 144(2):175-80. PubMed ID: 20153789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical penetration enhancers: a patent review.
    Ahad A; Aqil M; Kohli K; Chaudhary H; Sultana Y; Mujeeb M; Talegaonkar S
    Expert Opin Ther Pat; 2009 Jul; 19(7):969-88. PubMed ID: 19552513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.